Date:04-May-2024  Time: 4:31 AM
 
 
        
Sterling Biotech Ltd
Quarters:       (Rs. In Crores)
ParticularsMar 2019Dec 2018Sep 2018Jun 2018
Type4Qtr3Qtr2Qtr1Qtr
Net Sales88.9694.9581.9683.67
Other Income-2.110.681.831.93
Total Income86.8595.6383.7885.60
Total Expenditure 72.4883.6169.553089.81
Operating Profit14.3712.0214.24-3004.21
Interest-23.93-102.33147.50237.45
Gross Profit38.29114.35-133.27-3241.66
Depreciation61.4861.4761.4661.44
Tax0.000.000.000.00
Deferred Tax898.7015.91-58.59-993.90
Reported Profit After Tax-921.8936.97-136.13-2309.20
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com